Standardized chemoembolization protocol boosts liver cancer patient survival

November 30, 2008 DiagnosticImaging.com. Standardized chemoembolization protocol boosts liver cancer patient survival By H.A. Abella Results from the largest and longest trial of its kind suggest that patients with intermediate and advanced hepatocellular carcinomas who undergo systematic treatment with three chemotherapeutic agents and arterial embolization plus imaging follow-up have better survival rates than those who undergo nonstandardized chemoembolization regimes. That was the message delivered Sunday at the 2008 RSNA meeting by principal investigator Dr. Eleni Liapi, an interventional radiologist at Johns Hopkins University.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC